PKTXOTCPharmaceutical PreparationsFiscal year ends December 31

ProtoKinetix, Inc.

Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 10-K on Sep 3, 2026

$0.00+0.00 (0.00%)

Close on Oct 16, 2026

Market cap: $78.61K
P/E (TTM): –
Dividend yield: –

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Quarter	Reported	Time	Revenue	EPS (GAAP)	EPS (adjusted)
Q4 FY2015 Ended Dec 31, 2015	Jan 6, 2016	During market hours	–	–	–

Press releases

Announcements ProtoKinetix filed with the SEC

Nov 21, 2025, 11:57 AM ET
As Chief Executive Officer I want to extend our appreciation for all your support and thoughtfulness during
Regulation FD disclosure · EX-99.1 to Form 8-K
Nov 19, 2025, 5:19 PM ET
Incorporated Mourns the Loss of President and Chief Executive Officer Clarence E. Smith; Appointment of Michael Guzzetta as His Successor
Regulation FD disclosure · EX-99.1 to Form 8-K/A
Nov 17, 2025, 8:36 AM ET
Incorporated Mourns the Loss of President and Chief Executive Officer Clarence E. Smith; Appointment of Michael Guzzetta as His Successor
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K